Patent · US Active

Anti-B7-H3 antibody

US12187800B2 · kind B2 · utility

0Cited by
0References
17Claims
0Family size

Assignees

Inventors

Key dates

Filing dateNov 22, 2018
Grant dateJan 7, 2025
Priority date
Expiry dateApr 30, 2041

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N33/57492
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention encompasses antibodies and fragments thereof that bind to an extracellular domain of B7H3, and uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.